Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,248,134
+$160,684 QoQ
Shares Held
4,960
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#2,338
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sompo Asset Management Co., Ltd. holds $25,742,524 across 9 Drug Manufacturers - General names. ABBV ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
67,060 | $8,617,210 | |
| 2 | JNJ |
Johnson & Johnson
|
24,001 | $6,095,533 | |
| 3 | LLY |
ELI LILLY & Co
|
3,230 | $3,874,159 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
40,494 | $2,333,264 | |
| 5 | BIIB |
Biogen Inc.
|
8,596 | $1,857,251 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
4,960 | $1,248,134 | |
| 7 | AMGN |
Amgen Inc
|
2,010 | $727,861 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,930 | $622,856 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,248,134 | 4,960 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,087,450 | 5,000 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,231,561 | 5,390 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,296,624 | 5,600 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,100,726 | 5,930 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,242,453 | 5,930 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,053,761 | 5,930 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,056,518 | 5,350 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $965,657 | 5,630 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,056,180 | 5,800 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,137,036 | 13,790 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,815,550 | 12,180 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,678,735 | 12,460 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,663,822 | 10,440 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,057,295 | 12,730 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,716,545 | 12,790 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,519,347 | 9,920 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,023,351 | 18,650 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,175,736 | 30,840 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,836,981 | 26,300 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,540,275 | 31,430 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,236,860 | 29,910 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,794,181 | 35,410 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,076,160 | 35,120 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,556,079 | 36,220 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,670,459 | 35,050 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||